IL6 and colitis: Several studies have confirmed the A2BR pro-inflammatory roleby demonstrating that A2BR blockade with selective antagonistsdecreases IL-6 levels and neutrophil activation, resulting in decreased intestinaldamage in mice suffering from colitis (33,34) or infected withC.